UK: Merits of any Takeda bid for Shire questioned, shares slide

TOKYO (Reuters) - A potential acquisition of London-listed Shire by Takeda Pharmaceutical was greeted with investor scepticism about it merits on Thursday, with shares in the Japanese drug maker tumbling 7 percent.
UK: Merits of any Takeda bid for Shire questioned, shares slide UK: Merits of any Takeda bid for Shire questioned, shares slide Reviewed by Shahid Karimi on March 29, 2018 Rating: 5

Post Comments

No comments:

Powered by Blogger.